"Hydantoins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS.
| Descriptor ID |
D006827
|
| MeSH Number(s) |
D03.383.129.308.432.555
|
| Concept/Terms |
Hydantoins- Hydantoins
- Imidazolidine-2,4-Diones
- Imidazolidine 2,4 Diones
|
Below are MeSH descriptors whose meaning is more general than "Hydantoins".
Below are MeSH descriptors whose meaning is more specific than "Hydantoins".
This graph shows the total number of publications written about "Hydantoins" by people in this website by year, and whether "Hydantoins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 3 | 3 |
| 2008 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydantoins" by people in Profiles.
-
Robinson VM, Bharucha DB, Mahaffey KW, Dorian P, Kowey PR. Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial. Am Heart J. 2017 Mar; 185:43-51.
-
Dorian P, Al-Khalidi HR, Hohnloser SH, Brum JM, Dunnmon PM, Pratt CM, Holroyde MJ, Kowey P. Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial. J Am Coll Cardiol. 2008 Sep 23; 52(13):1076-83.
-
Conway E, Musco S, Kowey PR. New horizons in antiarrhythmic therapy: will novel agents overcome current deficits? Am J Cardiol. 2008 Sep 22; 102(6A):12H-19H.
-
Guo D, Zhao X, Wu Y, Liu T, Kowey PR, Yan GX. L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):196-203.
-
Kerr CR, Connolly SJ, Kowey P, Page RL, Pritchett EL, Ruda MY, Ruzyllo W, Wilkinson WE. Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease. Am J Cardiol. 2006 Jul 15; 98(2):215-8.
-
Pritchett EL, Kowey P, Connolly S, Page RL, Kerr C, Wilkinson WE. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm. Am Heart J. 2006 May; 151(5):1043-9.
-
Wu Y, Carlsson L, Liu T, Kowey PR, Yan GX. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes. J Cardiovasc Electrophysiol. 2005 Aug; 16(8):898-904.